Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

NCT02619448 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
RADIATION: 70 Gy in 20 fractions over 4 weeks

Sponsor

State University of New York - Upstate Medical University